Disease Progression and Disease Prevention in Hepatology and Gastroenterology PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Disease Progression and Disease Prevention in Hepatology and Gastroenterology PDF full book. Access full book title Disease Progression and Disease Prevention in Hepatology and Gastroenterology by P.R. Galle. Download full books in PDF and EPUB format.
Author: P.R. Galle
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 296
Get Book Here
Book Description
Here are the proceedings of the Falk Symposium 150, "Disease Progression and Disease Prevention in the Gastrointestinal Tract", held in Berlin, Germany, October, 2005. Pathogenic processes are described as well as primary and secondary prevention and treatment of disease. The symposium generated new perspectives on the various different pathogenic mechanisms in gastrointestinal organs. The book summarizes the state of the art in these different disease entities, as presented at the meeting.
Author: P.R. Galle
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 296
Get Book Here
Book Description
Here are the proceedings of the Falk Symposium 150, "Disease Progression and Disease Prevention in the Gastrointestinal Tract", held in Berlin, Germany, October, 2005. Pathogenic processes are described as well as primary and secondary prevention and treatment of disease. The symposium generated new perspectives on the various different pathogenic mechanisms in gastrointestinal organs. The book summarizes the state of the art in these different disease entities, as presented at the meeting.
Author: Beate Fessler
Publisher:
ISBN: 9783933186768
Category :
Languages : en
Pages : 52
Get Book Here
Book Description
Author: Sharad C Shah
Publisher: JP Medical Ltd
ISBN: 9352501896
Category : Medical
Languages : en
Pages : 169
Get Book Here
Book Description
This book is a concise guide to the prevention and management of cirrhosis of the liver. Divided into four sections, the book begins with an overview of the condition, followed by detailed discussion on the different levels of prevention, both major and minor. The third section examines aetiologies and their prevention and the final chapter covers fibrosis (scarring) reversal. This practical guide provides clinicians and trainees with evidence-based direction on the diagnosis, treatment and management of cirrhosis and its many complications. Key Points Concise guide to prevention and management of liver cirrhosis Provides detail on different levels of prevention Covers fibrosis (scarring) reversal Offers evidence-based direction on diagnosis, treatment and management of cirrhosis and its complications
Author: Jawad Ahmad
Publisher: John Wiley & Sons
ISBN: 1118517342
Category : Medical
Languages : en
Pages : 597
Get Book Here
Book Description
Mount Sinai Expert Guides: Hepatology will provide gastroenterology and hepatology trainees with an extremely clinical and accessible handbook covering the major liver diseases and symptoms, their diagnosis and clinical management. Perfect as a point-of-care resource on the hospital wards and also as a refresher for board exam preparation, the focus throughout is on providing rapid reference, essential information on each disease to allow for quick, easy browsing and assimilation of the must-know information. All chapters follow a consistent template including the following features: - An opening bottom-line/key points section - Classification, pathogenesis and prevention of disease - Evidence-based diagnosis, including relevant algorithms, laboratory and imaging tests, and potential pitfalls when diagnosing a patient - Disease management including commonly used medications with dosages, when to perform surgery, management algorithms and how to prevent complications - How to manage special populations, ie, in pregnancy, children and the elderly - The very latest evidence-based results, major society guidelines (AASLD/EASL) and key external sources to consult In addition, the book comes with a companion website housing extra features such as case studies with related questions for self-assessment, key patient advice and ICD codes. Each guide also has its own mobile app available for purchase, allowing you rapid access to the key features wherever you may be. If you're specialising in hepatology and require a concise, practical guide to the clinical management of liver disease, bought to you by one of world's leading hospitals, then this is the perfect book for you. This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from iTunes, Google Play or the MedHand Store.
Author: N. Hiyashi
Publisher: Springer Science & Business Media
ISBN: 9780792387961
Category : Medical
Languages : en
Pages : 140
Get Book Here
Book Description
In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe. This book, the proceedings of the Falk Workshop on 'Prevention of Progression in Chronic Liver Disease - An Update on SNMC (Stronger Neo-Minophagen C)' (Part IV of the XII Falk Liver Week, in honour of Hans Popper's 100th birthday) held in Freiburg, Germany, on 22 October 2003, is devoted to the understanding of basic mechanisms of fibrogenesis, the state of the art of non-invasive markers of disease progression that may substitute liver biopsy in the future, and of other predictive parameters indicating disease progression, in particular the development of hepatocellular carcinoma. All these problems are particularly relevant for chronic hepatitis C. A better characterization of so-called non-responders for the treatments available is crucial for the development of new strategies preventing or postponing disease progression. Such strategies should influence fibrogenesis and, thus, cirrhosis formation as well as the development of life threatening complications of liver cirrhosis, including hepatocellular carcinoma. In this volume, the available information on SNMC as an approach to prevent progression of chronic liver disease is discussed by several internationally renowned authors who report on the mechanisms of liver fibrogenesis and fibrolysis, on non-invasive markers of disease progression, and on hepatocellular carcinoma as one of the major complications of liver cirrhosis nowadays. Finally, experts from Japan report on their knowledge and experience concerning the drug SNMC/Glycyrrhizine in the prevention of cirrhosis and HCC, and first study results from Europe are presented.
Author: Michael J. G. Farthing
Publisher: John Libbey Eurotext
ISBN: 9782742004393
Category : Medical
Languages : en
Pages : 140
Get Book Here
Book Description
John Libbey Eurotext continues to publish the proceedings of the gastroenterology seminars taught by leading European specialists and organised by the European Association for Gastroenterology and Endoscopy (EAGE). The aim of the book is to describe major clinical and therapeutic progress observed during 2002: gastrooesophageal reflux disease, inflammatory bowel disease, irritable bowel syndrome, colon cancer, liver cancer.
Author: Luis Rodrigo
Publisher: BoD – Books on Demand
ISBN: 1839686235
Category : Medical
Languages : en
Pages : 260
Get Book Here
Book Description
This book discusses clinical advances in hepatology, with a focus on metabolic diseases and chronic hepatitis C. The development of direct-acting antiviral (DAA) agents for the treatment of hepatitis C virus (HCV) infection in 2010 has completely transformed the management of this disease. This transformative nature of DAA therapy underpins the goal of the World Health Organization (WHO) to eliminate HCV infection as a public health threat by 2030. The advantages of using these therapies include high efficacy (sustained virological response rate >95%) with minimal side effects, good tolerability, easy drug administration (once-daily oral dosing) and short duration of treatment (8-12 weeks). The commercialization of second-generation DAA agents due to their high effectiveness, few side-effects and pangenotypic action. This transformative nature of DAA therapy underpins the goal of the WHO to eliminate HCV infection as a public health threat by 2030.
Author: J.L. Boyer
Publisher: Springer Science & Business Media
ISBN: 9780792387602
Category : Medical
Languages : en
Pages : 374
Get Book Here
Book Description
Liver cirrhosis is a major clinical problem worldwide and is associated with significant morbidity and mortality from its complications, such as liver cell insufficiency with coagulopathy and hepatic encephalopathy, portal hypertension with ascites and gastrointestinal bleeding, hepatorenal syndrome, HCC development and others. This volume, the proceedings of Falk Symposium 115 held in Basel, Switzerland, October 22-24, 1999 (Part II of the Basel Liver Week 1999; XI International Congress of Liver Diseases) covers our present knowledge of the aetiologies and early stages of liver cirrhosis development. Based on this information, strategies are discussed that are aimed at the prevention, early diagnosis and therapy of chronic liver diseases, thus preventing their progression to cirrhosis and its complications, including HCC development. The main topics mentioned above are complemented by three state-of-the-art chapters on modern aspects of medicine in general and hepatology in particular as well as their perspectives beyond the year 2000: `Molecular Medicine', `New Hepatitis Viruses' and `Genetic Liver Diseases: Diagnosis and Therapy'. Introductory chapters focusing on the more basic aspects of the biology of live cells as well as on the mechanisms underlying fibrogenesis, cholestasis and inflammation will be followed by a detailed discussion of the clinically most important causes of liver cirrhosis worldwide: hepatitis viruses B, C and D; toxins (alcohol, drugs and others) as well as metabolic liver diseases (haemochromatosis, Wilson disease, alpha-1-antitrypsin deficiency, porphyria cutanea tarda and protoporphyria). This book, therefore, will interest clinically oriented basic scientists as well as those in clinical practice, givng an update on many aspects of modern hepatology and its perspectives in the next millennium.
Author: Steven L. Flamm
Publisher: Elsevier Health Sciences
ISBN: 0323548865
Category : Medical
Languages : en
Pages :
Get Book Here
Book Description
Consultations of Gastroenterology practitioners are frequently sought for many complex issues relating to acute and chronic liver disease. Many of the disease entities are uncommon and complicated in scope. Liver disease may occur in the setting of other chronic medical conditions and involve other organ systems, with recommendations for diagnostic strategies and therapeutic approaches somewhat challenging. Serious consequences are often the rule with misdiagnosed or inadequately treated liver disease. Dr. Flamm has provided a framework for approaching consultation for common liver-related problems for the gastroenterology practitioner. Articles are devoted to the following topics: Common Findings and Interpretation for the Clinician; Genetic Testing in Liver Disease: What to Order and When; Acute Liver Failure; Liver Disease in Oncology Patients; Primary Sclerosing Cholangitis: What the Gastroenterologist/Hepatologist Needs to Know; An Update on the Treatment and Follow up of Patients with PBC; Wilson’s Disease: Diagnosis, Treatment, and Follow Up; Follow Up of the Post-Liver Transplantation Patient: A Primer for the Practicing Gastroenterologist; Liver Disease in Patients on Total Parenteral Nutrition; Treatment Strategies in NAFLD: What’s Coming; Resistance Testing in Chronic HCV; and HCV genotype 3: Treatment Approach and Natural History.
Author: Emad Hamdy Gad
Publisher: BoD – Books on Demand
ISBN: 1839628693
Category : Medical
Languages : en
Pages : 146
Get Book Here
Book Description
Non-alcoholic fatty liver disease (NAFLD) is a major medical challenge because of its increasing prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. In the near future, it will become the major form of chronic liver disease in adults and children and the leading indication for liver transplantation. It can be detected by noninvasive and invasive tools, and its treatment depends mainly on lifestyle modification to prevent disease progression and its related sequelae. This book provides information on NAFLD prevalence, etiology, pathogenesis, pathology, diagnosis, and treatment. Chapters cover such topics as experimental work related to the disease, other diseases related to NAFLD, and noninvasive tools for diagnosis.
